Literature DB >> 18274826

Association of SLC22A4/5 polymorphisms with steroid responsiveness of inflammatory bowel disease in Japan.

Seiya Nakahara1, Yoshiaki Arimura, Katsuhiko Saito, Akira Goto, Satoshi Motoya, Yasuhisa Shinomura, Atsushi Miyamoto, Kohzoh Imai.   

Abstract

PURPOSE: We investigated the association between steroid responsiveness and single nucleotide polymorphisms of SLC22A4/A5 located within inflammatory bowel disease 5 locus. Our goal is personalized steroid therapy adjusted to match individual variations in drug responsiveness in each inflammatory bowel disease patient.
METHODS: Unrelated Japanese cohorts of 94 patients with Crohn's, 94 patients with ulcerative colitis, and 257 healthy control subjects were consecutively enrolled in this study. Genotyping and haplotype analysis focusing on steroid responsiveness was performed by using 15 single nucleotide polymorphisms.
RESULTS: The G allele of -368T > G in SLC22A5, in which strong linkage disequilibrium was observed and the limited diversity of three haplotypes was estimated, was significantly associated with steroid resistance in Japanese patients with Crohn's disease (P = 0.016). Haplotype analysis between -446C > T and -368T > G in the SLC22A5 promoter region showed that the CG allele appeared to be a risk haplotype for steroid resistance (CG: odds ratio, 4.13; 95 percent confidence interval, 1.41-12.1; P = 0.016).
CONCLUSIONS: This extensive linkage disequilibrium may form a general risk haplotype for steroid resistance in Crohn's disease in Japanese. Further analyses of the pharmacogenomics of steroid responsiveness are warranted to achieve the goal of individualized steroid therapy against inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18274826     DOI: 10.1007/s10350-008-9208-5

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  4 in total

1.  Haplotype in the IBD5 region is associated with refractory Crohn's disease in Slovenian patients and modulates expression of the SLC22A5 gene.

Authors:  Katja Repnik; Uroš Potočnik
Journal:  J Gastroenterol       Date:  2011-06-22       Impact factor: 7.527

2.  The SLC2A14 gene, encoding the novel glucose/dehydroascorbate transporter GLUT14, is associated with inflammatory bowel disease.

Authors:  Mandana Amir Shaghaghi; Haonan Zhouyao; Hongbin Tu; Hani El-Gabalawy; Gary H Crow; Mark Levine; Charles N Bernstein; Peter Eck
Journal:  Am J Clin Nutr       Date:  2017-09-27       Impact factor: 7.045

Review 3.  Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Authors:  Curtis D Klaassen; Lauren M Aleksunes
Journal:  Pharmacol Rev       Date:  2010-01-26       Impact factor: 25.468

4.  Low-Frequency IL23R Coding Variant Associated with Crohn's Disease Susceptibility in Japanese Subjects Identified by Personal Genomics Analysis.

Authors:  Kei Onodera; Yoshiaki Arimura; Hiroyuki Isshiki; Kentaro Kawakami; Kanna Nagaishi; Kentaro Yamashita; Eiichiro Yamamoto; Takeshi Niinuma; Yasuyoshi Naishiro; Hiromu Suzuki; Kohzoh Imai; Yasuhisa Shinomura
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.